Cargando…

Improving the drug-likeness of inspiring natural products - evaluation of the antiparasitic activity against Trypanosoma cruzi through semi-synthetic and simplified analogues of licarin A

Neolignan licarin A (1) was isolated from leaves of Nectandra oppositifolia (Lauraceae) and displayed activity against trypomastigote forms of the etiologic agent of American trypanosomiasis, Trypanosoma cruzi. Aiming for the establishment of SAR, five different compounds (1a – 1e) were prepared and...

Descripción completa

Detalles Bibliográficos
Autores principales: Morais, Thiago R., Conserva, Geanne A. Alves, Varela, Marina T., Costa-Silva, Thais A., Thevenard, Fernanda, Ponci, Vitor, Fortuna, Ana, Falcão, Amílcar C., Tempone, Andre G., Fernandes, João Paulo S., Lago, João Henrique G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096397/
https://www.ncbi.nlm.nih.gov/pubmed/32214193
http://dx.doi.org/10.1038/s41598-020-62352-w
_version_ 1783510794131996672
author Morais, Thiago R.
Conserva, Geanne A. Alves
Varela, Marina T.
Costa-Silva, Thais A.
Thevenard, Fernanda
Ponci, Vitor
Fortuna, Ana
Falcão, Amílcar C.
Tempone, Andre G.
Fernandes, João Paulo S.
Lago, João Henrique G.
author_facet Morais, Thiago R.
Conserva, Geanne A. Alves
Varela, Marina T.
Costa-Silva, Thais A.
Thevenard, Fernanda
Ponci, Vitor
Fortuna, Ana
Falcão, Amílcar C.
Tempone, Andre G.
Fernandes, João Paulo S.
Lago, João Henrique G.
author_sort Morais, Thiago R.
collection PubMed
description Neolignan licarin A (1) was isolated from leaves of Nectandra oppositifolia (Lauraceae) and displayed activity against trypomastigote forms of the etiologic agent of American trypanosomiasis, Trypanosoma cruzi. Aiming for the establishment of SAR, five different compounds (1a – 1e) were prepared and tested against T. cruzi. The 2-allyl derivative of licarin A (1d) exhibited higher activity against trypomastigotes of T. cruzi (IC(50) = 5.0 μM and SI = 9.0), while its heterocyclic derivative 1e displayed IC(50) of 10.5 μM and reduced toxicity against NCTC cells (SI > 19.0). However, these compounds presented limited oral bioavailability estimation (<85%, Papp <1.0 × 10(−6) cm/s) in parallel artificial membrane permeability assays (PAMPA) due to excessive lipophilicity. Based on these results, different simplified structures of licarin A were designed: vanillin (2), vanillyl alcohol (3), isoeugenol (4), and eugenol (5), as well as its corresponding methyl (a), acetyl (b), O-allyl (c), and C-allyl (d) analogues. Vanillin (2) and its acetyl derivative (2b) displayed expressive activity against intracellular amastigotes of T. cruzi with IC(50) values of 5.5 and 5.6 μM, respectively, and reduced toxicity against NCTC cells (CC(50) > 200 μM). In addition, these simplified analogues showed a better permeability profile (Papp > 1.0 × 10(−6) cm/s) on PAMPA models, resulting in improved drug-likeness. Vanillyl alcohol acetyl derivative (3b) and isoeugenol methyl derivative (4a) displayed activity against the extracellular forms of T. cruzi (trypomastigotes) with IC(50) values of 5.1 and 8.8 μM respectively. Based on these results, compounds with higher selectivity index against extracellular forms of the parasite (1d, 1e, 3d, and 4a) were selected for a mechanism of action study. After a short incubation period (1 h) all compounds increased the reactive oxygen species (ROS) levels of trypomastigotes, suggesting cellular oxidative stress. The ATP levels were increased after two hours of incubation, possibly involving a high energy expenditure of the parasite to control the homeostasis. Except for compound 4a, all compounds induced hyperpolarization of mitochondrial membrane potential, demonstrating a mitochondrial imbalance. Considering the unique mitochondria apparatus of T. cruzi and the lethal alterations induced by structurally based on licarin A, these compounds are interesting hits for future drug discovery studies in Chagas disease.
format Online
Article
Text
id pubmed-7096397
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-70963972020-03-30 Improving the drug-likeness of inspiring natural products - evaluation of the antiparasitic activity against Trypanosoma cruzi through semi-synthetic and simplified analogues of licarin A Morais, Thiago R. Conserva, Geanne A. Alves Varela, Marina T. Costa-Silva, Thais A. Thevenard, Fernanda Ponci, Vitor Fortuna, Ana Falcão, Amílcar C. Tempone, Andre G. Fernandes, João Paulo S. Lago, João Henrique G. Sci Rep Article Neolignan licarin A (1) was isolated from leaves of Nectandra oppositifolia (Lauraceae) and displayed activity against trypomastigote forms of the etiologic agent of American trypanosomiasis, Trypanosoma cruzi. Aiming for the establishment of SAR, five different compounds (1a – 1e) were prepared and tested against T. cruzi. The 2-allyl derivative of licarin A (1d) exhibited higher activity against trypomastigotes of T. cruzi (IC(50) = 5.0 μM and SI = 9.0), while its heterocyclic derivative 1e displayed IC(50) of 10.5 μM and reduced toxicity against NCTC cells (SI > 19.0). However, these compounds presented limited oral bioavailability estimation (<85%, Papp <1.0 × 10(−6) cm/s) in parallel artificial membrane permeability assays (PAMPA) due to excessive lipophilicity. Based on these results, different simplified structures of licarin A were designed: vanillin (2), vanillyl alcohol (3), isoeugenol (4), and eugenol (5), as well as its corresponding methyl (a), acetyl (b), O-allyl (c), and C-allyl (d) analogues. Vanillin (2) and its acetyl derivative (2b) displayed expressive activity against intracellular amastigotes of T. cruzi with IC(50) values of 5.5 and 5.6 μM, respectively, and reduced toxicity against NCTC cells (CC(50) > 200 μM). In addition, these simplified analogues showed a better permeability profile (Papp > 1.0 × 10(−6) cm/s) on PAMPA models, resulting in improved drug-likeness. Vanillyl alcohol acetyl derivative (3b) and isoeugenol methyl derivative (4a) displayed activity against the extracellular forms of T. cruzi (trypomastigotes) with IC(50) values of 5.1 and 8.8 μM respectively. Based on these results, compounds with higher selectivity index against extracellular forms of the parasite (1d, 1e, 3d, and 4a) were selected for a mechanism of action study. After a short incubation period (1 h) all compounds increased the reactive oxygen species (ROS) levels of trypomastigotes, suggesting cellular oxidative stress. The ATP levels were increased after two hours of incubation, possibly involving a high energy expenditure of the parasite to control the homeostasis. Except for compound 4a, all compounds induced hyperpolarization of mitochondrial membrane potential, demonstrating a mitochondrial imbalance. Considering the unique mitochondria apparatus of T. cruzi and the lethal alterations induced by structurally based on licarin A, these compounds are interesting hits for future drug discovery studies in Chagas disease. Nature Publishing Group UK 2020-03-25 /pmc/articles/PMC7096397/ /pubmed/32214193 http://dx.doi.org/10.1038/s41598-020-62352-w Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Morais, Thiago R.
Conserva, Geanne A. Alves
Varela, Marina T.
Costa-Silva, Thais A.
Thevenard, Fernanda
Ponci, Vitor
Fortuna, Ana
Falcão, Amílcar C.
Tempone, Andre G.
Fernandes, João Paulo S.
Lago, João Henrique G.
Improving the drug-likeness of inspiring natural products - evaluation of the antiparasitic activity against Trypanosoma cruzi through semi-synthetic and simplified analogues of licarin A
title Improving the drug-likeness of inspiring natural products - evaluation of the antiparasitic activity against Trypanosoma cruzi through semi-synthetic and simplified analogues of licarin A
title_full Improving the drug-likeness of inspiring natural products - evaluation of the antiparasitic activity against Trypanosoma cruzi through semi-synthetic and simplified analogues of licarin A
title_fullStr Improving the drug-likeness of inspiring natural products - evaluation of the antiparasitic activity against Trypanosoma cruzi through semi-synthetic and simplified analogues of licarin A
title_full_unstemmed Improving the drug-likeness of inspiring natural products - evaluation of the antiparasitic activity against Trypanosoma cruzi through semi-synthetic and simplified analogues of licarin A
title_short Improving the drug-likeness of inspiring natural products - evaluation of the antiparasitic activity against Trypanosoma cruzi through semi-synthetic and simplified analogues of licarin A
title_sort improving the drug-likeness of inspiring natural products - evaluation of the antiparasitic activity against trypanosoma cruzi through semi-synthetic and simplified analogues of licarin a
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096397/
https://www.ncbi.nlm.nih.gov/pubmed/32214193
http://dx.doi.org/10.1038/s41598-020-62352-w
work_keys_str_mv AT moraisthiagor improvingthedruglikenessofinspiringnaturalproductsevaluationoftheantiparasiticactivityagainsttrypanosomacruzithroughsemisyntheticandsimplifiedanaloguesoflicarina
AT conservageanneaalves improvingthedruglikenessofinspiringnaturalproductsevaluationoftheantiparasiticactivityagainsttrypanosomacruzithroughsemisyntheticandsimplifiedanaloguesoflicarina
AT varelamarinat improvingthedruglikenessofinspiringnaturalproductsevaluationoftheantiparasiticactivityagainsttrypanosomacruzithroughsemisyntheticandsimplifiedanaloguesoflicarina
AT costasilvathaisa improvingthedruglikenessofinspiringnaturalproductsevaluationoftheantiparasiticactivityagainsttrypanosomacruzithroughsemisyntheticandsimplifiedanaloguesoflicarina
AT thevenardfernanda improvingthedruglikenessofinspiringnaturalproductsevaluationoftheantiparasiticactivityagainsttrypanosomacruzithroughsemisyntheticandsimplifiedanaloguesoflicarina
AT poncivitor improvingthedruglikenessofinspiringnaturalproductsevaluationoftheantiparasiticactivityagainsttrypanosomacruzithroughsemisyntheticandsimplifiedanaloguesoflicarina
AT fortunaana improvingthedruglikenessofinspiringnaturalproductsevaluationoftheantiparasiticactivityagainsttrypanosomacruzithroughsemisyntheticandsimplifiedanaloguesoflicarina
AT falcaoamilcarc improvingthedruglikenessofinspiringnaturalproductsevaluationoftheantiparasiticactivityagainsttrypanosomacruzithroughsemisyntheticandsimplifiedanaloguesoflicarina
AT temponeandreg improvingthedruglikenessofinspiringnaturalproductsevaluationoftheantiparasiticactivityagainsttrypanosomacruzithroughsemisyntheticandsimplifiedanaloguesoflicarina
AT fernandesjoaopaulos improvingthedruglikenessofinspiringnaturalproductsevaluationoftheantiparasiticactivityagainsttrypanosomacruzithroughsemisyntheticandsimplifiedanaloguesoflicarina
AT lagojoaohenriqueg improvingthedruglikenessofinspiringnaturalproductsevaluationoftheantiparasiticactivityagainsttrypanosomacruzithroughsemisyntheticandsimplifiedanaloguesoflicarina